[26-000980] mchb requires creation mouse colony breeding service in order to use for creation mouse colony breeding.
Active Purchase Order Awarded
- Contract number
- 75N92026P00036
- Awardee
-
Ozgene PTY LTD UEI M8PAJV4B5ZL4
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,686
Award facts
- Contract value 100% obligated
- $24,686.00 Current and potential, with all options
- Completion date 84% complete
- Current and potential, with all options
- NAICS code
- 112990 All Other Animal Production
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Boston, MA 02114, USA
Award details come from SAM.gov/FPDS.
About this award
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $24,686 firm fixed-price purchase order to Ozgene PTY LTD, an Australian genetic research company, on December 30, 2025. The contract, which carries no set-aside designation, is for the creation of a mouse colony breeding service to support NHLBI's biomedical research initiatives. The work will be performed in Boston, Massachusetts, with an ultimate completion date of December 29, 2026. Ozgene, headquartered in Bentley, Western Australia, brings specialized expertise in mouse model development and genetic engineering technologies essential for advanced cardiovascular and pulmonary research.
Ozgene has established a track record as a preferred vendor for NIH institutes, with prior awards from NHLBI, the National Institute of Allergy and Infectious Diseases, and the National Institute of Diabetes and Digestive and Kidney Diseases for similar genetic research services. The company's contract awards have consistently focused on highly specialized deliverables including mouse colony breeding, gene targeting vector services, and the creation of genetically modified mouse models for biomedical investigation. This award represents a continuation of NHLBI's reliance on Ozgene's competitive capabilities to provide precise, customized genetic research services that directly support the Institute's research mission in cardiovascular, lung, and blood diseases.
Quick answers
Who was awarded contract 75N92026P00036?
75N92026P00036 was awarded to Ozgene PTY LTD by National Heart Lung and Blood Institute (National Institutes of Health) on December 30, 2025.
How much is contract 75N92026P00036 worth?
The government has obligated $24,686 on 75N92026P00036.
Was contract 75N92026P00036 competed?
The extent of competition for 75N92026P00036 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award